Stifel Reiterates Buy Rating on Nurix (NRIX)
Stifel analyst Stephen Willey reiterated a Buy rating and $34.00 price target on Nurix (NASDAQ: NRIX).The analyst commented, "Updated P1a/b ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
